Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Biocon Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

02 May 2015 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Biocon Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

03 May 2015 Wright Reports 55 $75.00

Biocon Ltd.| Q4FY15 Result/Concall Update | A decent quarter; listing of Syngene - a key near term trigger

Biocon Ltd.|Q4FY15 Result/Concall Update A decent quarter; listing of Syngene - a key near term trigger Biocon (BIOS IN) re...

01 May 2015 IndiaNivesh Securities Pvt Ltd 5 $46.00

Thomson Reuters Stock Report - BIOCON LIMITED (BIOCON-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 May 2015 Thomson Reuters Stock Report 11 $25.00

Biocon Ltd.|Company Update | Syngene listing may raise Rs5.3bn for Biocon; maintain HOLD rating on the stock with PT of Rs463

Biocon Ltd.|Company Update Syngene listing may raise Rs5.3bn for Biocon; maintain HOLD rating on the stock with PT of Rs463 ...

23 Apr 2015 IndiaNivesh Securities Pvt Ltd 2 $12.00

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review Summary Biocon Limited (Biocon) is a is a fully-integr...

07 Apr 2015 GlobalData 58 $125.00

Is Biocon Ltd Oversold?

02 Apr 2015 Sadif Analytics Prime 12 $25.00

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review Summary Biocon Limited (Biocon) is a is a fully-integr...

04 Feb 2015 GlobalData 57 $125.00

MOSL: BIOCON (Sell) - Significant miss on earnings - High R&D, Opex costs drive margins to multi-qtr low

BIOCON 3QFY15: High R&D intensity weigh on profitability (BIOS IN, Mkt Cap USD1.3b, CMP INR413, TP INR410, 1% Downside, Sell...

27 Jan 2015 Motilal Oswal Securities Ltd. 12 $127.00

Biocon Ltd. | Q3FY15 Result/Concall Update | Though a muted quarter in terms of business, listing of Syngene remains a key near term trigger | Maintain HOLD rating with PT of Rs463 (from Rs479)

Biocon Ltd. | Q3FY15 Result/Concall Update Though a muted quarter in terms of business, listing of Syngene remains a key nea...

24 Jan 2015 IndiaNivesh Securities Pvt Ltd 4 $35.00